Return On Equity in % of Mersana Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mersana Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q1 2018 to Q3 2025.
  • Mersana Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2025 was 183 %.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2024 was -990 %, a 251% decline from 2023.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2023 was -282 %, a 57.9% decline from 2022.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2022 was -179 %, a 76.3% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 183 +585 Jul 1, 2025 Sep 30, 2025
Q2 2025 320 +654 Apr 1, 2025 Jun 30, 2025
Q1 2025 958 +1.22K Jan 1, 2025 Mar 31, 2025
Q4 2024 -990 -708 -251% Oct 1, 2024 Dec 31, 2024
Q3 2024 -401 -137 -51.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -334 -78 -30.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -261 -36.7 -16.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -282 -104 -57.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -264 -93 -54.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -256 -115 -82.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -224 -105 -88% Jan 1, 2023 Mar 31, 2023
Q4 2022 -179 -77.4 -76.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -171 -94.1 -122% Jul 1, 2022 Sep 30, 2022
Q2 2022 -141 -82.5 -142% Apr 1, 2022 Jun 30, 2022
Q1 2022 -119 -74.7 -168% Jan 1, 2022 Mar 31, 2022
Q4 2021 -101 -58.4 -136% Oct 1, 2021 Dec 31, 2021
Q3 2021 -77.2 -32 -70.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -58 -3.12 -5.68% Apr 1, 2021 Jun 30, 2021
Q1 2021 -44.4 +33.8 +43.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -43.1 -15.1 -54.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -45.2 -4.02 -9.77% Jul 1, 2020 Sep 30, 2020
Q2 2020 -54.9 -3.79 -7.41% Apr 1, 2020 Jun 30, 2020
Q1 2020 -78.2 -20.7 -36% Jan 1, 2020 Mar 31, 2020
Q4 2019 -27.9 +155 +84.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -41.1 +69.3 +62.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -51.1 +21.5 +29.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -57.5 +66.8 +53.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -182 Oct 1, 2018 Dec 31, 2018
Q3 2018 -110 Jul 1, 2018 Sep 30, 2018
Q2 2018 -72.6 Apr 1, 2018 Jun 30, 2018
Q1 2018 -124 Jan 1, 2018 Mar 31, 2018

Mersana Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -990 -708 -251% Jan 1, 2024 Dec 31, 2024
2023 -282 -104 -57.9% Jan 1, 2023 Dec 31, 2023
2022 -179 -77.4 -76.3% Jan 1, 2022 Dec 31, 2022
2021 -101 -58.4 -136% Jan 1, 2021 Dec 31, 2021
2020 -43.1 -15.1 -54.1% Jan 1, 2020 Dec 31, 2020
2019 -27.9 +155 +84.7% Jan 1, 2019 Dec 31, 2019
2018 -182 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.